Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
For the six months, sales was USD 549.53 million compared to USD 541.24 million a year ago. Net income was USD 78.46 million compared to USD 139.56 million a year ago. Basic earnings per share from continuing operations was USD 0.5 compared to USD 0.89 a year ago. Diluted earnings per share from continuing operations was USD 0.49 compared to USD 0.86 a year ago.